Roflumilast Cream 0.15% Leads to Consistent Eczema Improvements for Diverse Skin Types
Roflumilast cream (Zoryve) 0.15% treatment leads to significant atopic dermatitis symptom improvements across a diverse set of ethnicities, races, and Fitzpatrick skin types, according to new findings presented at the European Academy of Dermatology & …